Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Designation crawled time : 12:00 save search
Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML
Published: 2024-04-22 (Crawled : 12:00) - globenewswire.com
KURA | News | $18.74 3.02% 2.93% 1M
|
Health Technology
|
| O: 4.56%
H: 4.64%
C: -0.76%
designation for aml therapy
Lexeo Therapeutics Granted FDA Fast Track Designation for LX2006, an AAV-Based Gene Therapy Candidate for the Treatment of Friedreich’s Ataxia Cardiomyopathy
Published: 2024-04-16 (Crawled : 12:00) - globenewswire.com
LXEO | News | $12.17 -3.87% -4.03% 82K
|
|
| O: 5.32%
H: 0.0%
C: -2.63%
lx2006 fda candidate granted treatment designation for therapeutics therapy
PureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck Cancers
Published: 2024-04-11 (Crawled : 12:00) - biospace.com/
PTCHF | $2.61 19.97% 4.1K
|
n/a
|
| O: 4.65%
H: 0.0%
C: 0.0%
lyt-200 fda designation for
Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Newly Diagnosed Unfit AML with RARA gene overexpression
Published: 2024-04-09 (Crawled : 12:00) - biospace.com/
SYRS | $5.17 3.61% 3.48% 170K
|
Health Technology
|
| O: 2.16%
H: 23.21%
C: 16.03%
fda treatment designation for aml
Solid Biosciences Receives Rare Pediatric Disease Designation from the FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003
Published: 2024-04-01 (Crawled : 12:00) - globenewswire.com
SLDB | $9.08 0.44% 0.44% 300K
|
Health Technology
|
| O: -9.02%
H: 0.0%
C: -7.65%
sgt-003 fda rare candidate disease designation duchenne therapy
MIMEDX Provides Update on AXIOFILL® Request for Designation (“RFD”) from FDA
Published: 2024-03-27 (Crawled : 12:00) - globenewswire.com
MDXG | $6.505 2.28% 2.23% 750K
|
Health Technology
|
| O: 0.26%
H: 2.29%
C: -0.39%
axiofill fda update designation
Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi Syndrome
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
TNXP | $0.1574 1.29% 1.27% 1.6M
|
Health Technology
|
| O: 0.0%
H: 0.03%
C: -5.2%
tnx-2900 fda rare disease treatment pharmaceuticals designation
Lisata Therapeutics Announces U.S. FDA Rare Pediatric Disease Designation Granted to LSTA1 for the Treatment of Osteosarcoma
Published: 2024-03-21 (Crawled : 12:00) - globenewswire.com
LSTA | $2.67 -2.08% 13K
|
Manufacturing
|
| O: 0.32%
H: 9.68%
C: 8.06%
fda rare disease granted treatment designation therapeutics
Keros Therapeutics Announces U.S. FDA Fast Track Designation for KER-050 in Lower-Risk Myelodysplastic Syndromes
Published: 2024-03-14 (Crawled : 12:00) - globenewswire.com
KROS | $55.27 -0.91% -0.92% 480K
|
Health Technology
|
| O: -0.95%
H: 0.34%
C: -3.27%
ker-050 fda designation therapeutics
EDAP Announces FDA Breakthrough Device Designation for Focal One® in the Treatment of Deep Infiltrating Rectal Endometriosis
Published: 2024-03-04 (Crawled : 12:00) - globenewswire.com
EDAP | $7.13 -0.28% -0.28% 18K
|
Health Technology
|
| O: 11.76%
H: 1.18%
C: 0.0%
one fda device treatment designation
Unicycive Therapeutics Announces Orphan Drug Designation Granted for UNI-494 by the U.S. Food and Drug Administration for the Prevention of Delayed Graft Function in Kidney Transplant Patients
Published: 2024-03-04 (Crawled : 12:00) - globenewswire.com
UNCY | $1.07 -6.96% -7.48% 240K
|
Professional, Scientific, and T...
|
| O: 1.25%
H: 2.46%
C: -8.02%
uni-494 drug kidney granted food designation therapeutics
Acurx Announces FDA Has Granted an End of Phase 2 Meeting for Ibezapolstat for C. difficile Infection and the European Medicines Agency Granted SME Designation for Ibezapolstat EU Development
Published: 2024-02-27 (Crawled : 12:00) - prnewswire.com
ACXP | $1.98 -2.29% 30K
|
Professional, Scientific, and T...
|
| O: 1.54%
H: 1.52%
C: -5.15%
fda granted ibezapolstat infection designation meeting
Krystal Biotech Receives FDA Fast Track Designation for Inhaled Oncology Candidate KB707 to Treat Solid Tumors of the Lung
Published: 2024-02-13 (Crawled : 12:00) - globenewswire.com
KRYS | News | $162.175 3.13% 3.04% 220K
|
Health Technology
|
| O: -2.92%
H: 0.84%
C: -3.35%
kb707 fda lung candidate biotech tumors treat designation
BioXcel Therapeutics Receives FDA Fast Track Designation for BXCL701 for Treatment of Small Cell Neuroendocrine Prostate Cancer (SCNC)
Published: 2024-02-12 (Crawled : 12:00) - globenewswire.com
BTAI | News | $2.965 4.04% 3.88% 410K
|
Health Technology
|
| O: 13.74%
H: 2.08%
C: -18.75%
bxcl701 fda cancer cell treatment designation therapeutics
Eplontersen granted U.S. FDA Fast Track designation for patients with transthyretin-mediated amyloid cardiomyopathy
Published: 2024-02-08 (Crawled : 12:00) - prnewswire.com
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: -8.5%
H: 2.46%
C: 2.46%
IONS | $41.85 1.9% 1.86% 630K
|
Health Technology
|
| O: 0.2%
H: 1.37%
C: 0.68%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -6.81%
H: 3.02%
C: 2.42%
fda granted designation eplontersen
FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)
Published: 2024-02-07 (Crawled : 12:00) - globenewswire.com
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: 0.43%
H: 0.67%
C: 0.21%
ALEC | $5.33 3.1% 3.0% 550K
|
Health Technology
|
| O: 2.15%
H: 5.51%
C: 3.73%
fda dementia designation grants therapy
Arvinas and Pfizer’s Vepdegestrant (ARV-471) Receives FDA Fast Track Designation for the Treatment of Patients with ER+/HER2- Metastatic Breast Cancer
Published: 2024-02-06 (Crawled : 12:00) - globenewswire.com
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.34%
H: 3.99%
C: 3.15%
ARVN | $33.96 -2.69% -2.77% 530K
|
Health Technology
|
| O: 0.91%
H: 5.05%
C: 4.9%
arv-471 fda breast cancer treatment designation
BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjugate Candidate BNT325/DB-1305
Published: 2024-01-31 (Crawled : 12:00) - globenewswire.com
BNTX | News | $88.53 0.59% 0.59% 360K
|
Health Technology
|
| O: -1.03%
H: 2.91%
C: 1.11%
bnt325 fda candidate designation
Krystal Biotech Receives Orphan Drug Designation from the Japanese MHLW for Beremagene Geperpavec-svdt (B-VEC)
Published: 2023-12-19 (Crawled : 12:00) - globenewswire.com
KRYS | News | $162.175 3.13% 3.04% 220K
|
Health Technology
|
| O: 1.18%
H: 3.71%
C: 2.63%
drug biotech designation
Lexeo Therapeutics Granted FDA Fast Track Designation and Orphan Drug Designation for LX2020, an AAV-Based Gene Therapy Candidate for PKP2 Arrhythmogenic Cardiomyopathy (ACM)
Published: 2023-12-18 (Crawled : 12:00) - globenewswire.com
LXEO | News | $12.17 -3.87% -4.03% 82K
|
|
| O: -0.08%
H: 15.92%
C: 8.8%
lx2020 fda drug candidate granted designation therapeutics therapy
Gainers vs Losers
| 79% | 21% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 870K
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.